Eli Lilly and CompanyLLY

Where LLY's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$1,220.51+5.81 (+0.48%)Previous close
NYSEHealthcare

LLY Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
LLY Net Debt / EBITDA historyLLY Net Debt / EBITDA from Sep 2023 to Jun 2026: low 1.14, high 2.62, latest 1.31.1.021.451.882.312.73Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 1.99

LLY Net Debt / EBITDA by year

Yearly range of LLY’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.5 to 3.0, averaging 1.7.

LLY Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.11.21.31.3
20251.31.62.21.3
20242.02.22.52.0
20231.82.12.62.6
20221.61.61.71.6
20211.51.51.61.6
20201.51.72.01.5
20192.02.43.02.0
20180.51.01.60.5
20171.71.92.21.8
20161.11.21.31.1

Get notified when LLY Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.